Marksans Pharma Limited

Marksans Pharma Limited (MARKSANS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

marksanspharma.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹332.20
Market cap
15,046 Cr
Stock P/E
28.1
P/B
4.93
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales531 Cr586 Cr560 Cr591 Cr642 Cr682 Cr71 Cr620 Cr720 Cr754 Cr856 Cr841 Cr
Operating expenses (approx.)417 Cr453 Cr450 Cr462 Cr506 Cr543 Cr58 Cr520 Cr576 Cr594 Cr661 Cr628 Cr
EBITDA114 Cr133 Cr110 Cr128 Cr136 Cr139 Cr13 Cr100 Cr144 Cr161 Cr195 Cr213 Cr
OPM %21.4%22.7%19.6%21.7%21.1%20.4%17.8%16.1%20.1%21.3%22.8%25.3%
Other income19 Cr5 Cr17 Cr15 Cr11 Cr28 Cr2 Cr6 Cr22 Cr20 Cr35 Cr25 Cr
Interest2 Cr3 Cr5 Cr3 Cr3 Cr3 Cr0.34 Cr6 Cr6 Cr6 Cr6 Cr7 Cr
Depreciation18 Cr22 Cr21 Cr20 Cr20 Cr21 Cr2 Cr23 Cr27 Cr24 Cr24 Cr25 Cr
Profit before tax114 Cr113 Cr100 Cr120 Cr125 Cr143 Cr12 Cr77 Cr133 Cr151 Cr200 Cr207 Cr
Tax %26.3%26.4%22.6%25.8%21.5%26.7%21.9%24.0%25.6%24.5%25.5%22.8%
Net profit84 Cr83 Cr78 Cr89 Cr98 Cr105 Cr9 Cr58 Cr99 Cr114 Cr149 Cr159 Cr
EPS (₹)₹1.84₹1.84₹1.73₹1.96₹2.13₹2.31₹2.00₹1.29₹2.17₹2.50₹3.27₹3.47

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,000 Cr1,134 Cr1,376 Cr1,491 Cr1,852 Cr2,177 Cr262 Cr2,951 CrSign in for TTM
Operating expenses (approx.)868 Cr942 Cr1,037 Cr1,232 Cr1,513 Cr1,719 Cr209 Cr2,350 CrSign in for TTM
EBITDA132 Cr192 Cr340 Cr259 Cr339 Cr459 Cr53 Cr601 CrSign in for TTM
OPM %13.2%17.0%24.7%17.4%18.3%21.1%20.2%20.4%Sign in for TTM
Other income5 Cr0.33 Cr7 Cr42 Cr59 Cr50 Cr7 Cr83 CrSign in for TTM
Interest10 Cr9 Cr8 Cr8 Cr9 Cr11 Cr1 Cr24 CrSign in for TTM
Depreciation23 Cr27 Cr36 Cr45 Cr52 Cr74 Cr8 Cr99 CrSign in for TTM
Profit before tax104 Cr157 Cr302 Cr248 Cr338 Cr424 Cr50 Cr561 CrSign in for TTM
Tax %22.9%23.2%21.1%24.5%21.4%25.6%24.1%25.1%Sign in for TTM
Net profit80 Cr121 Cr239 Cr187 Cr265 Cr315 Cr38 Cr420 CrSign in for TTM
EPS (₹)₹1.87₹2.86₹5.76₹4.51₹6.41₹6.92₹8.40₹9.22Sign in for TTM
Dividend payout %———5.7%3.8%7.2%7.7%8.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital41 Cr41 Cr41 Cr41 Cr45 Cr45 Cr5 Cr45 Cr
Reserves502 Cr595 Cr846 Cr1,161 Cr1,700 Cr2,020 Cr242 Cr2,978 Cr
Borrowings100 Cr19 Cr19 Cr41 Cr42 Cr29 Cr2 Cr30 Cr
Other liabilities151 Cr229 Cr304 Cr376 Cr384 Cr566 Cr73 Cr779 Cr
Total liabilities804 Cr897 Cr1,228 Cr1,640 Cr2,190 Cr2,681 Cr324 Cr3,861 Cr
Fixed assets (net)198 Cr220 Cr234 Cr342 Cr380 Cr676 Cr58 Cr625 Cr
CWIP——6 Cr0.69 Cr7 Cr5 Cr0.90 Cr15 Cr
Investments0 Cr0 Cr0 Cr0.43 Cr0.54 Cr27 Cr0.07 Cr0 Cr
Inventories293 Cr242 Cr404 Cr424 Cr485 Cr618 Cr85 Cr972 Cr
Trade receivables177 Cr243 Cr271 Cr395 Cr417 Cr453 Cr54 Cr645 Cr
Cash & bank34 Cr94 Cr212 Cr349 Cr382 Cr403 Cr50 Cr634 Cr
Other assets102 Cr98 Cr100 Cr129 Cr519 Cr498 Cr77 Cr970 Cr
Total assets804 Cr897 Cr1,228 Cr1,640 Cr2,190 Cr2,681 Cr324 Cr3,861 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———99 Cr237 Cr230 Cr21 Cr458 Cr
Cash from investing———-42 Cr-259 Cr-141 Cr-5 Cr-248 Cr
Cash from financing———80 Cr198 Cr-69 Cr-7 Cr-71 Cr
Net cash flow———137 Cr176 Cr21 Cr9 Cr138 Cr
Free cash flow (OCF − Capex)———53 Cr184 Cr22 Cr3 Cr328 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %17.5%24.8%33.6%21.3%19.2%20.6%20.5%19.0%
ROE %15.3%19.7%32.0%15.5%15.0%16.4%0.0%13.7%
Debtor days6478729682767580
Inventory days259238351286288338409369
Days payable94103146135137147148128
Cash conversion cycle230213276247233267336321
Debt / equity0.180.030.020.030.020.010.00940.0098
Current ratio2.282.693.023.374.914.784.625.17
Net debt / EBITDA0.000.000.000.00-1.00-0.82-0.89-1.01

Compare with peers

Loading peers…